Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:40 am Sale |
2024-11-08 | 13G | XPO Logistics, Inc. XPO |
FMR LLC | 2,515,012 2.160% |
-5,226,866 (-67.51%) |
Filing History |
| 2024-11-12 10:40 am Sale |
2024-11-08 | 13G | WillScot Holdings Corporation WSC |
FMR LLC | 4,959,036 2.630% |
-6,901,791 (-58.19%) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | Vistra Corp. VST |
FMR LLC | 22,872,039 6.657% |
5,181,960 (+29.29%) |
Filing History |
| 2024-11-12 10:40 am Sale |
2024-11-08 | 13G | VSE Corporation VSEC |
FMR LLC | 2,323,572 12.614% |
-33,752 (-1.43%) |
Filing History |
| 2024-11-12 10:40 am Sale |
2024-11-08 | 13G | Wells Fargo & Company WFC |
FMR LLC | 195,949,869 5.756% |
-15,695,397 (-7.42%) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | Xenon Pharmaceuticals Inc. XENE |
FMR LLC | 6,867,684 9.064% |
1,211,762 (+21.42%) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | vTv Therapeutics Inc. VTVT |
FMR LLC | 178,200 7.324% |
178,200 (New Position) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | Zenas BioPharma, Inc. ZBIO |
FMR LLC | 2,000,000 5.026% |
2,000,000 (New Position) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | Warrior Met Coal, Inc. HCC |
FMR LLC | 3,210,530 6.137% |
1,493,241 (+86.95%) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | ZoomInfo Technologies Inc. ZI |
FMR LLC | 33,053,421 9.048% |
20,038,865 (+153.97%) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR LLC | 18,678,526 9.113% |
-3,760,598 (-16.76%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | StepStone Group Inc. STEP |
FMR LLC | 3,942,702 5.803% |
1,295,418 (+48.93%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Vaxcyte, Inc. PCVX |
FMR LLC | 15,746,667 12.837% |
1,533,302 (+10.79%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Stewart Information Services Corporation STC |
FMR LLC | 2,488,342 8.989% |
2,488,342 (New Position) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
FMR LLC | 8,363,529 3.040% |
-2,533,757 (-23.25%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Roivant Sciences Ltd. ROIV |
FMR LLC | 49,145,056 6.645% |
49,145,056 (New Position) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | SiTime Corporation SITM |
FMR LLC | 3,469,843 14.999% |
372,478 (+12.03%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
FMR LLC | 5,486,468 14.999% |
503,117 (+10.10%) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR LLC | 5,271,108 8.634% |
-1,031,366 (-16.36%) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Vertiv Holdings Co VRT |
FMR LLC | 12,188,535 3.248% |
-16,838,566 (-58.01%) |
Filing History |